NEW DELHI: Revised maximum retail prices (MRPs) of 1,364 anti-cancer medicine formulations came into effect across the country on Monday, with the Centre estimating annual savings of Rs 3,540.38 crore for consumers.
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, has capped trade margins on the MRPs of 137 anti-cancer drugs following recommendations of an expert committee constituted by the Directorate General of Health Services on October 17, 2026.
According to the NPPA, 85 pharmaceutical companies had reported revised MRPs for 1,364 formulations covering 121 drugs as of November 8.
Of these, 679 brands reported price reductions of more than 50 per cent, while the highest reported reduction in MRP stands at 96.45 per cent.
The revised prices are intended to make cancer treatment more affordable by reducing the cost burden on patients and their families.
The NPPA has advised consumers to check the revised MRP printed on medicine packs and verify prices through the Pharma Sahi Daam mobile application or its official website.
Chemists and hospital pharmacies cannot charge more than the revised MRP. Consumers can lodge complaints regarding overcharging or other pricing-related violations through the Pharma Jan Samadhan portal or by contacting the NPPA helpline at 1800-111-255.
